AASK


Also found in: Acronyms.

AASK

African American Study of Kidney Disease & Hypertension. A clinical trial comparing ramipril, amlodipine and metoprolol in preventing the progression of hypertensive renal disease in African Americans; interim analysis triggered early termination of the amlodipine arm because of worse outcomes compared to the other 2 arms.

AASK

Cardiology A clinical trial–African American Study of Kidney Disease and Hypertension Pilot Study that studied the relationship between anti-hypertensive therapy and progression of renal disease See Hypertension.
References in periodicals archive ?
All study staff were trained and certified at the beginning of the study and annually thereafter in all AASK procedures: implementation of protocol; data entry; GFR testing; blood pressure measurements using random-zero blood pressure monitors, and the collection, processing, and shipping of biological specimens.
Lawrence Agodoa, a kidney specialist and NIH director of AASK, cautioned patients to continue taking prescribed blood pressure medications until they have worked out an alternative with their doctor.
The "Telemagic" software system AASK uses to match kids with families gives the group 21st-century tools, but its greatest strength is human, not tech- nological: Twenty-two families in 14 states across the country serve as volunteer recruiters.
Data Source: AASK, a clinical trial with an initial 4-year randomized phase comparing intensive BP control with standard BP control in 1,094 black adults, as well as an observational cohort phase with a further 4-8 years of extended follow-up.
Results from AASK and from many other recent trials have shown that these drugs work best for preserving renal function and blocking progression of proteinuria.
AASK to see your GP immediately and explain all of this to him.
AASK your local Crime Prevention Officer, based at the police station, for advice.
These include: the REIN trial (Ramipril Efficacy In Nephropathy) involving a European proteinuria population, the RENAAL trial (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) and the IDNT trial (Irbesartan Diabetic Nephropathy Trial) involving world wide type 2 diabetes as well as the AASK (African American Study of Kidney Disease and Hypertension) involving hypertensive African Americans.
In AASK, achieving the 140/85 mm Hg goal slowed renal disease progression so much that "it was almost what we'd find with normal aging," said AASK chair Dr.
AASK your insurance man or independent financial adviser about Income Protection policies.